Bharat Biotech intranasal COVID vaccine approved by Centre, to be available on CO-WIN Roshni Dhar24 Dec 2022 11:12 AM GMTThe central government has approved the use of Bharat Biotech's nasal Covid vaccine iNCOVACC to be included in the country's vaccination programme as...
Health Bulletin 24/ December/ 2022 Roshni Dhar24 Dec 2022 11:02 AM GMTHere are the top health stories for the day:Fully prepared to deal with any eventuality, say Delhi hospitals amid coronavirus scareAmid concerns over...
Centre nod to Bharat Biotech nasal COVID vaccine iNCOVACC, to be availabile in private hospitals Ruchika Sharma23 Dec 2022 10:01 AM GMTiNCOVACC is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilized SARS-CoV-2 spike protein.
Include intranasal COVID vaccine iNCOVACC in CoWIN portal: Bharat Biotech urges Centre Ruchika Sharma12 Dec 2022 7:00 AM GMTCurrently, Bharat Biotech's Covaxin, Serum Institute's Covishield and Covovax, Russian Sputink V, and Biological E Ltd's Corbevax are listed in the...
DCGI panel to hold discussion on intranasal "Five Arms" booster dose iNCOVACC on Nov 15: Sources Ruchika Sharma14 Nov 2022 8:00 AM GMTIt has now announced that iNCOVACC (BBV154) has received approval under Restricted Use in Emergency Situation for ages 18 and above.
Intranasal COVID vaccine: Bharat Biotech seeks DCGI nod for phase 3 study of iNCOVACC in 5-18 age group Ruchika Sharma12 Sep 2022 5:58 AM GMTiNCOVACC is a recombinant replication deficient adenovirus vectored vaccine with a pre-fusion stabilised spike protein.
Intranasal COVID vaccine INCOVACC will be global game changer, says Bharat Biotech Chairman Roshni Dhar8 Sep 2022 10:26 AM GMTBharat Biotech's iNCOVACC, the world's first intranasal vaccine for Covid-19 which received approval for emergency use in India on Tuesday, will be a...
Health Bulletin 7/September/2022 Roshni Dhar7 Sep 2022 11:30 AM GMTHere are the top health stories for the day:NEET PG 2022 counselling expected to commence from September 19Putting an end to the long wait by the...
Bharat Biotech Chairman says Intranasal vaccine iNCOVACC will be global game changer Ruchika Sharma7 Sep 2022 5:30 AM GMTiNCOVACC has been specifically formulated to allow intranasal delivery through nasal drops.
COVID-19: Bharat Biotech intranasal vaccine found safe in booster trials Ruchika Sharma17 Aug 2022 9:30 AM GMTBBV154 has the double benefit of enabling faster development of variant-specific vaccines and easy nasal delivery that helps mass immunization protect...
Bharat Biotech's intranasal booster vaccine may be potential game changer, say expert MD Bureau13 March 2022 6:55 AM GMTThe clinical trials for phase three of the BBV154 vaccine developed by the Hyderabad-based firm started at the All India Institute of Medical Sciences...
Bharat Biotech seeks DCGI nod for study of intra-nasal COVID vaccine as booster dose Ruchika Sharma21 Dec 2021 6:30 AM GMTNew Delhi: Indian vaccine maker Bharat Biotech said on Monday it has submitted an application to the country's drug regulator to conduct a late-stage...
